Purified and specific cytoplasmic pollen extract: a non-hormonal alternative for the treatment of menopausal symptoms

References

• Santoro N, Randolph JF. Reproductive hormones and the menopause transition. Obstet Gynecol Clin North Am. 2011;38(3):455–466.
   PubMed Web of Science ®Google Scholar
• Davis S, Lambrinoudaki I, Lumsden M, et al. Menopause. Nat Rev Dis Primers. 2015;1(1):15004.
   PubMedGoogle Scholar
• Freedman RR. Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid Biochem Mol Biol. 2014;142:115–120.
   PubMed Web of Science ®Google Scholar
• Depypere HT, Comhaire FH. Herbal preparations for the menopause: beyond isoflavones and black cohosh. Maturitas. 2014;77(2):191–194.
   PubMed Web of Science ®Google Scholar
• Mintziori G, Lambrinoudaki I, Goulis DG, et al. EMAS position statement: non-hormonal management of menopausal vasomotor symptoms. Maturitas. 2015; 81(3):410–413.
   PubMed Web of Science ®Google Scholar
• Non hormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause. 2015;11:1155–1174.
   Google Scholar
• Stanley RG, Linskens HF. Pollen biology biochemistry management. Berlin, Heidelberg, New York: Springer; 1974.
   Google Scholar
• Komosinska-Vassev K, Olczyk P, Kaźmierczak J, et al. Bee pollen: chemical composition and therapeutic application. Evid Based Complement Alternat Med. 2015;2015:1–6.
   Web of Science ®Google Scholar
• Bogdanov S. Pollen: production, nutrition and health: a review. Bee Product Science; 2014 [cited 2020 Jan 29]. Available from: http://www.bee-hexagon.net/
   Google Scholar
• Rimpler M. Von Bienen gesammelte Blutenpollen: Eigen-schaften und Verwendung. Arztezeitschrift Naturheilver-Fahren. 2003;3:158–165.
   Google Scholar
• Goss JA. Development, physiology, and biochemistry of corn and wheat pollen. Bot Rev. 1968;34:333–359.
   Web of Science ®Google Scholar
• Bollen LS. Polbax extract. Acute toxicity study in the rat Scantox test report Lab N° 25550 29.09; 1997.
   Google Scholar
• Jensen D. Romert. Limited test for acute oral toxicity in mice of Royal Sport Extract. Genotox project N°114-001 N° F11-005; 1988.
   Google Scholar
• Kraft M. Reverse mutation assay using bacteria (Salmonella typhimurium) with pollen extract GCFem. Bioservice Scientific Laboratories Project 072759 BSL Bioservice report 072759; 2007.
   Google Scholar
• Kraft M. Reverse mutation assay using bacteria (Salmonella typhimurium) with polbax pollen extract. Bioservice Scientific Laboratories Project 072760 BSL Bioservice report 072760; 2007.
   Google Scholar
• Hellström AC, Muntzing J. The pollen extract femal – a non-estrogenic alternative to hormone therapy in women with menopausal symptoms. Menopause. 2012;19(7):825–829.
   PubMed Web of Science ®Google Scholar
• Espié M. Bouffées de chaleur et cancer du sein: quelle prise en charge efficace et sans risque? Cancer Féminin. 2013;III:1–16.
   Google Scholar
• Seeger H, Ruan X, Neubauer H, et al. Membrane-initiated effects of Serelys® on proliferation and apoptosis of human breast cancer cells. Gynecol Endocrinol. 2017;34:1–4.
   PubMed Web of Science ®Google Scholar
• Goldstein S, Espie M, Druckmann R. Does purified Swedish pollen extract, a nonhormonal treatment for vasomotor symptoms, inhibit the CYP2D6 enzyme system? Menopause. 2015;11:1212–1214.
   Google Scholar
• Biglia N, Bounos VE, De Seta F, et al. Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update. Ecancer. 2019;13:909.
   PubMed Web of Science ®Google Scholar
• Capozzi A, Lello S. Purified pollen extract and vasomotor symptoms management. GIOG. 2018;40(1):7–9.
   Web of Science ®Google Scholar
• Winther K, Rein E, Hedman C. Femal®, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study. Climateric. 2005;8(2):162–170.
   PubMed Web of Science ®Google Scholar
• Elia D, Mares P. Evaluation de la tolérance et de l’efficacité d’un complément alimentaire Sérélys® (Femal®) chez les femmes en période de ménopause. Génésis. 2008;135:12–15.
   Google Scholar
• Druckmann R, Lachowsky M, Elia D. Evaluation de la qualité de vie, de l’efficacité et de la tolérance de Sérélys chez les femmes en période de péri-ménopause et ménopause. Genesis. 2015;183:10–13.
   Google Scholar
• Kimura H, Gruber P. Perimenopausal symptoms such as hot flushes and mood swings are reduced by a standardised pollen pistil extract. Climacteric. 2002;5(Suppl. 1):85.
   Google Scholar
• D’Alterio MN, Giancane E, Cornacchia S, et al. GCFem, PI82, vitamin E in menopause treatment: benefits for peri and postmenopausal neurovegetative symptoms. Multidisc J Women’s Health. 2015;4(1).
   Google Scholar
• Paszkowski T, Skrzypulec-Plinta V. Assessment of quality of life in women using Femelis Meno. Prz Menopauzalny. 2018;17(2):77–85.
   PubMedGoogle Scholar
• Fait T, Sailer M, Regidor PA. Prospective observational study to evaluate the efficacy and safety of the pollen extract Sérélys® in the management of women with menopausal symptoms. Gynecol Endocrinol. 2019;35(4):360–363.
   PubMed Web of Science ®Google Scholar
• Van Keep PA, Lehert P. Le syndrome prémenstruel; une étude épidémiologique en France. Contracept Fertil Steril. 1980;8:775.
   Google Scholar
• Dimmock P, Wyatt KM, Jones PW, et al. Efficacy of selective serotonin reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet. 2000;356:1131–1136.
   PubMed Web of Science ®Google Scholar
• Panay N. Management of premenstrual syndrome. J Fam Plann Reprod Health Care. 2009;35(3):187–194.
   PubMedGoogle Scholar
• Panay N, Studd J. The management of PMDD through ovarian cycle suppression. In: O’Brien S, Rapkin AJ, Schmidt PJ, editors. Premenstrual syndromes: PMS and PMDD. Informa UK; 2007. p. 121–130.
   Google Scholar
• Winther K, Hedman C. Assessment of the effects of the herbal remedy Femal on the symptoms of premenstrual syndrome a randomized, double blind, placebo-controlled study. Curr Ther Res. 2002;5:344–353.
   Google Scholar
• Gerhardsen G, Hansen AV, Killi M, et al. The efficacy of Femal® in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study. Adv Ther. 2008;25(6):595–607.
   PubMed Web of Science ®Google Scholar
• Winther K, Campbell-Tofte J, Motawei AM, et al. A double blinded, randomized, placebo controlled, parallel study of pollen pistil extract (Serelys) on women reporting irritability as predominant PMS symptoms. J Herb Med. 2018;12:23–32.
   Web of Science ®Google Scholar
• Giannini A, Caretto M, Genazzani A, et al. Optimizing quality of life through sex steroids by their effects on neurotransmitters. Climacteric. 2019;1:55–59.
   Google Scholar
• Rossmanith WG, Ruebberdt W. What causes hot flushes? The neuroendocrine origin of vasomotor symptoms in the menopause. Gynecol Endocrinol. 2009;25(5):303–314.
   PubMed Web of Science ®Google Scholar
• Berendsen HH. The role of serotonin in hot flushes. Maturitas. 2000;3:155–164.
   Google Scholar
• Rance NE, Dacks PA, Mittelman-Smith MA, et al. Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes. Front Neuroendocrinol. 2013;3:211–227.
   Google Scholar
• Prague JK, Roberts RE, Alexander AN, et al. Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet. 2017;10081:1809–1820.
   Google Scholar
• Depypere H, Timmerman D, Donders G, et al. Treatment of menopausal vasomotor symptoms with fezolinetant, a neurokinin 3 receptor antagonist: a phase 2a trial. J Clin Endocrinol Metabol. 2019;12:5893–5905.
   Google Scholar
• Appel K, Veit J, Diaz Ph, et al. Purified and specific cytoplasmic pollen extract, PureCyTonin®, a non-hormonal treatment for hot flushes, inhibits serotonin reuptake. Gynecol Reprod Endocrinol Metabol.; 2020;1; in press.
   Google Scholar
• Svensson U. Report EUDAKG Eurofins Steins Laboratorium. Method EU 152/2009. AR-16-LW-035803-012016; 2009.
   Google Scholar
• Berridge KC, Kringelbach ML. Pleasure systems in the brain. Neuron. 2015;3:646–664.
   Google Scholar
• Zichella L, Falaschi P, Fioretti P, et al. Effects of different dopamine agonists and antagonists on post-menopausal hot flushes. Maturitas. 1986;3:229–237.
   Google Scholar
• Sárvári M, Kalló I, Hrabovszky E, et al. Estradiol replacement alters expression of genes related to neurotransmission and immune surveillance in the frontal cortex of middle-aged, ovariectomized rats. Endocrinology. 2010;151(8):3847–3862.
   PubMed Web of Science ®Google Scholar
• Doshi SB, Agarwal A. The role of oxidative stress in menopause. J Midlife Health. 2013;4(3):140–146.
   PubMedGoogle Scholar
• Krotkiewski M, Belboul A, Palm S, et al. The effect of SOD-active plant substance Polbax on oxygen free radical (OFR) generation and blood cell rheology. Clin Hemorheol. 1995;4:641–647.
   Google Scholar